BIOA
Income statement / Annual
Last year (2024), BioAge Labs, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, BioAge Labs, Inc.'s net income was -$71.11 M.
See BioAge Labs, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$59.04 M
|
$33.89 M
|
$30.52 M
|
| General & Administrative Expenses |
$19.16 M
|
$14.51 M
|
$9.45 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$19.16 M
|
$14.51 M
|
$9.45 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$78.19 M
|
$48.40 M
|
$39.97 M
|
| Cost And Expenses |
$78.19 M
|
$48.40 M
|
$39.97 M
|
| Interest Income |
$9.63 M
|
$2.43 M
|
$465.00 K
|
| Interest Expense |
$2.37 M
|
$7.79 M
|
$241.00 K
|
| Depreciation & Amortization |
$167.00 K
|
$162.00 K
|
$129.00 K
|
| EBITDA |
-$68.58 M |
-$55.90 M |
-$39.35 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$7.09 M
|
-$15.45 M
|
$247.00 K
|
| Income Before Tax |
-$71.11 M
|
-$63.85 M
|
-$39.72 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$71.11 M
|
-$63.85 M
|
-$39.72 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-6.63 |
-8.55 |
-5.32 |
| EPS Diluted |
-6.63 |
-8.55 |
-5.32 |
| Weighted Average Shares Out |
$10.73 M
|
$7.47 M
|
$7.46 M
|
| Weighted Average Shares Out Diluted |
$10.73 M
|
$7.47 M
|
$7.46 M
|
| Link |
|
|
|
